artesunic acid has been researched along with Colorectal Cancer in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Du, B; Feng, Q; Gan, S; Huang, Q; Huang, Z; Liu, Z; Lu, L; Qi, X; Wang, Y; Zhang, R; Zhuang, X | 1 |
| Chen, Y; Du, Q; Gong, Z; Pan, D; Peng, J; Sun, R; Wang, Q; Zhou, J | 1 |
| Das, P; Kumar, VL; Verma, S | 2 |
| Cui, C; Feng, H; Feng, Z; Fu, J; Fu, Z; Han, Z; Liu, J; Shi, X; Tong, H; Wang, Y | 1 |
| Picot, S | 1 |
| Cowan, M; Efferth, T; Finlayson, C; Ganapathi, S; Jansen, H; Kovacsevics, H; Kremsner, PG; Krishna, S; Kumar, D; Saeed, ME; Ster, IC | 1 |
| Li, LN; Sun, ZX; Tian, ZY; Wang, L; Yuan, SJ; Zhang, HD | 1 |
| Li, LN; Sun, ZX; Wang, L; Yang, DX; Yuan, SJ; Zhang, HD | 1 |
1 trial(s) available for artesunic acid and Colorectal Cancer
| Article | Year |
|---|---|
A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer.
Topics: Administration, Oral; Aged; Artemisinins; Artesunate; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Demography; Double-Blind Method; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Pilot Projects; Placebos; Staining and Labeling; Survival Analysis; Treatment Outcome | 2015 |
8 other study(ies) available for artesunic acid and Colorectal Cancer
| Article | Year |
|---|---|
Artesunate Inhibits the Cell Growth in Colorectal Cancer by Promoting ROS-Dependent Cell Senescence and Autophagy.
Topics: Animals; Apoptosis; Artesunate; Autophagy; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Colorectal Neoplasms; Endoribonucleases; Mice; Protein Serine-Threonine Kinases; Reactive Oxygen Species | 2022 |
Dual-targeting of artesunate and chloroquine to tumor cells and tumor-associated macrophages by a biomimetic PLGA nanoparticle for colorectal cancer treatment.
Topics: Animals; Artesunate; Biomimetics; Cell Line, Tumor; Chloroquine; Colorectal Neoplasms; Mice; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Tumor Microenvironment; Tumor-Associated Macrophages | 2023 |
Artesunate suppresses inflammation and oxidative stress in a rat model of colorectal cancer.
Topics: 1,2-Dimethylhydrazine; Administration, Oral; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Artesunate; Aspirin; Colorectal Neoplasms; Cyclooxygenase 2; Down-Regulation; Drug Administration Schedule; Interleukin-1beta; Male; Neoplasms, Experimental; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Treatment Outcome | 2019 |
Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of β-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis.
Topics: 1,2-Dimethylhydrazine; Aberrant Crypt Foci; Animals; Apoptosis; Artemisinins; Artesunate; Aspirin; bcl-2-Associated X Protein; beta Catenin; Cell Proliferation; Colorectal Neoplasms; DNA Fragmentation; Down-Regulation; Male; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A | 2017 |
Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10.
Topics: Animals; Artemisinins; Artesunate; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cytokines; Cytotoxicity, Immunologic; Dinoprostone; Humans; Immunosuppression Therapy; Interleukin-10; Killer Cells, Natural; Lymphocyte Activation; Mice; Transforming Growth Factor beta1; Tumor Escape; Vascular Endothelial Growth Factor A | 2015 |
The Other Face of Artesunate: Southern Drug to Treat Northern Diseases.
Topics: Artemisinins; Artesunate; Colorectal Neoplasms; Female; Humans; Male | 2015 |
Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; beta Catenin; Blotting, Western; Cell Proliferation; Colorectal Neoplasms; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Signal Transduction; Wnt Proteins; Xenograft Model Antitumor Assays | 2007 |
Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; beta Catenin; Blotting, Western; Cadherins; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Proteins; Subcellular Fractions | 2008 |